Abstract
The realization that for a vast number of toxic effects, not the given compound itself was responsible but rather a metabolite that was produced from the compound, brought about an enormous step forward in chemical carcinogenesis and in toxicology in general (1–15). In chemical mutagenesis and in chemical carcinogenesis very often coumpounds, which by themselves are chemically inert, will produce mutagenic and carcinogenic effects. A prime example of this is the polycyclic aromatic hydrocarbons, which consisting of condensed aromatic rings are chemically inert, yet do produce mutagenic and carcinogenic effects. During the last 10 to 20 years researchers have started to realize that this is because they are metabolized to electrophilic metabolites which chemically react and combine with nucleophilic sites in the tissue (1–15). These nucleophilic sites include nitrogen atoms, sulphur atoms, and oxygen atoms in nucleic acids, in proteins and in carbohydrates, e.g. in carbohydrates which are parts of cellular membranes. This brings about two levels of control, the first determined by the chemical properties of the reactive metabolite, the second determined by the enzymic control of its concentration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Oesch, F. (1973) Xenobiotica 3, 305–340.
Miller, E.C. & Miller, J.A. (1974) in Molecular Biology of Cancer, ed. Busch, H. ( Academic, New York ), pp. 377.
Jerina, D.M. & Daly, J.W. (1974) Science 185, 573–582.
Sims, P. & Grover, P.L. (1974) Adv. Cancer Res. 20, 165–274.
Heidelberger, C. (1975) A. Rev. Biochem. 44, 79–121.
Nebert, D.W., Robinson, J.R., Niwa, A., Kumaki, K. & Poland, A.P. (1975) J. Cell Physiol. 85, 393–414.
Wood, A.W., Wislocki, P.G., Chang, R.L., Levin, W., Lu, A.Y.H., Yagi, H., Hernandez, O., Jerina, D.M. & Conney, A.H. (1976) Cancer Res. 36, 3358–3366.
Oesch, F. & Glatt, H.R. (1976) in Screening Tests in Chemical Carcinogenesis, eds. Montesano, R., Bartsch, H. & Tomatis, L. (IARC Scientific Publications No. 12, Lyon), pp. 255–295.
Jerina, D.M., Lehr, R.E., Yagi, H., Hernandez, O., Dansette, D.M., Wislocki, P.G., Wood, A.W., Chang, R.L., Levin, W. & Conney, A.H. (1976) in In Vitro Metabolic Activation in Muta–genesis Testing, eds. de Serres, C.F.J., Fouts, J.R., Bend, J.R. & Philpot, R.M. ( North Holland Biochemical Press, Amsterdam ), pp. 159–177.
Arias, I.M. & Jakoby, W.B. (1976) Kroc Foundation Series 6, Raven Press, New York.
Ullrich, V., Hildebrandt, A., Roots, I., Estabrock, R.W. & Conney, A.H. (1977) Microsomes and Drug Oxidation, Perga—mon Press, Oxford.
Oesch, F. (1979) in Mechanism of Toxic Action on Some Target Organs, eds. Chambers, P.L. & Günzel, P. ( Springer—Verlag, Heidelberg ), pp. 215–227.
Oesch, F. (1980) in Quantitative Aspects of Risk Assessment in Chemical Carcinogenesis, eds. Clemmesen, J., Conning, D.M., Henschler, D. & Oesch, F. ( Springer Verlag, Heidelberg ), pp. 179–194.
Guenthner, T.M. & Oesch, F. (1981) in Polycyclic Hydrocarbons and Cancer, eds. Gelboin, H. & Ts’o, P.O.P. ( Academic Press, New York ), pp. 183–212.
Guenthner, T.M. & Oesch, F. (1981) TIPS 2, 129–132.
Jung, R., Beermann, D., Glatt, H.R. & Oesch, F. (1981) Mutat. Res. 81, 11–19.
Stasiecki, P., Oesch, F., Bruder, G., Jarasch, E.D. & Franke, W.W. (1980) Eur. J. Cell Biol. 21, 79–92.
Oesch, F. (1979) in Progress in Drug Metabolism, eds. Bridges, J.W. & Chasseaud, L.F. ( John Wiley, Chichester, England ), Vol. 3, pp. 253–301.
Booth, J., Hewer, A., Keysell, G.R. & Sims, P. (1975) Xenobiotica 5, 197–203.
Sugiura, M., Yamazoe, Y., Kamataki, T. & Kato, R. (1980) Cancer Res. 40, 2910–2914.
Bentley, P., Oesch, F. & Glatt, H.R. (1977) Arch. Toxicol. 39, 65–75.
Lehr, R.E. & Jerina, D.M. (1977) Arch. Toxicol. 39, 1–6.
Kapitulnik, J., Wislocki, P.G., Levin, W., Yagi, H., Jerina, D.M. & Conney, A.H. (1978) Cancer Res. 38, 354–358.
Kapitulnik, J., Wislocki, P.G., Levin, W., Yagi, H., Thakker, D.R., Akagi, H., Koreeda, M., Jerina, D.M. & Conney, A.H. (1978) Cancer Res. 38, 2661–2665.
Levin, W., Wood, A.W., Wislocki, P.G., Chang, R.L., Kapitulnik, J., Mah, H.D., Yagi, H., Jerina, D.M. & Conney, A.H. (1978) Polycycl. Hydrocarb. Cancer 1, 189–202.
Slaga, T.J., Bracken, W.J., Gleason, G., Levin, W., Yagi, H., Jerina, D.M. & Conney, A.H. (1979) Cancer Res. 39, 67–71.
Slaga, T.J., Viaje, A., Bracken, W.M., Berry, D.L., Fischer, S.M., Miller, D.R. & Leclerc, S.M. (1977) Cancer Lett. 3, 23–30.
Bentley, P. & Oesch, F. (1975) FEBS Lett. 59, 291–295.
Guenthner, T.M., Bentley, P. & Oesch, F. (1981) Methods Enzymol. 77, 344–349.
Bentley, P. & Oesch, F. (1975) FEBS Lett. 59, 296–299.
McCann, J., Choi, E., Yamasaki, E. & Ames, B.N. (1975) Proc. Nat. Acad. Sci. USA 72, 5135–5139.
Glatt, H.R., Schwind, H., Zajdela, F., Croisy, A., Jacquignon, P.C. & Oesch, F. (1978) Mutat. Res. 66, 307–328.
Glatt, H.R. & Oesch, F. (1977) Arch. Toxicol. 39, 87–96.
Ayengar, P.K., Hayaishi, 0., Nakajima, M. & Tomida, I. (1959) Biochim. Biophys. Acta 33, 111–119.
Vogel, K., Bentley, P., Platt, K.L. & Oesch, F. (1980) J. Biol. Chem. 255, 9621–9625.
Glatt, H.R., Vogel, K., Bentley, P. & Oesch, F. (1979) Nature 277, 319–320.
Glatt, H.R., Billings, R., Platt, K.L. & Oesch, F. (1981) Cancer Res. 41, 270–277.
Kapitulnik, J., Levin, W., Conney, A.H., Yagi, A.H. & Thakker, D.R. (1977) Nature 266, 378–380.
Nebert, D.W. & Gelboin, H.V. (1968) J. biol. Chem. 243, 6242–6249.
Oesch, F., Jerina, D.M. & Daly, J. (1971) Biochim. Biophys. Acta 227, 685–691.
Oesch, F., Kaubisch, N., Jerina, D.M. & Daly, W. (1971) Biochemistry 10, 4858–4866.
Oesch, F. & Daly, J. (1972) Biochem. Biophys. Res. Commun. 46, 1713–1719.
Oesch, F., Jerina, D.M., Daly, J.W. & Rice, J.M. (1973) Chem.–Biol. Interact. 6, 189–202.
Oesch, F. (1974) Biochem. J. 139, 77–88.
Grover, P.L., Hewer, A, & Sims, P. (1971) FEBS Lett. 18, 76–80.
Bücker, M., Glatt, H.R., Platt, K.L., Avnir, D., Ittah, Y., Blum, J. & Oesch, F. (1978) Mutat. Res. 66, 337–348.
Walker, C.H., Bentley, P. & Oesch, F. (1978) Biochim. Biophys. Acta 539, 427–434.
Glatt, H.R., Lorenz, J., Fleischmann, R., Remmer, H., Ohnhaus, E.E., Kaltenbach, E., Tegtmeyer, F., Rüdiger, H. & Oesch, F. (1980) in Microsomes, Drug Oxidations and Chemical Carcinogenesis, eds. Coon, M.J., Conney, A.H., Estabrook, R.W., Gelboin, H.V., Gillette, J.R. & O’Brian, P.J. (Academic Press, New York ), Vol. II, pp. 651–654.
Schmassmann, H.U., Glatt, H.R. & Oesch, F. (1976) Anal. Biochem. 74, 94–104.
Oesch, F., Glatt, H.R. & Schmassmann, H. (1976) Biochem. Pharmacol. 26, 603–607.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Oesch, F. (1982). Chemical Carcinogenesis by Polycyclic Aromatic Hydrocarbons. In: Nicolini, C. (eds) Chemical Carcinogenesis. NATO Advanced Study Institutes Series, vol 52. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4334-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4334-9_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4336-3
Online ISBN: 978-1-4684-4334-9
eBook Packages: Springer Book Archive